Aura Biosciences, Inc. (AURA) Form 10-K Annual Reports
Aura Biosciences, Inc. (AURA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AURA
CIK: 1501796
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMiriam Herrero Paredes
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-01 | — | SCHEDULE 13G Filing | 0001470831-26-000917 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | 4 Filing | 0001946505-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | 4 Filing | 0002148785-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | 4 Filing | 0001997710-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | 4 Filing | 0002042910-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-09-01 | 4 Filing | 0002148701-26-000008 | View SEC Doc Filr Page |
| S-8 | 2026-09-01 | — | S-8 | 0001193125-26-378494 | View SEC Doc Filr Page |
| EFFECT | 2026-08-20 | — | EFFECT Filing | 9999999995-26-002723 | View SEC Doc Filr Page |
| CORRESP | 2026-08-18 | — | CORRESP Filing | 0001193125-26-355417 | View SEC Doc Filr Page |
| UPLOAD | 2026-08-17 | — | UPLOAD Filing | 0000000000-26-008094 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000913 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001019056-26-000129 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-08-12 | 3 Filing | 0001946505-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-08-10 | 3 Filing | 0002148785-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-08-10 | 3 Filing | 0002148701-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004960 | View SEC Doc Filr Page |
| S-3 | 2026-08-11 | — | S-3 | 0001193125-26-344699 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-343429 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-343408 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335157 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002193 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | 4 | 0001193125-26-298542 | View SEC Doc Filr Page |
| 3 | 2026-07-08 | 2026-07-07 | 3 | 0001193125-26-298538 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-03 | 8-K | 0001193125-26-297992 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-07-01 | 4 | 0001193125-26-292685 | View SEC Doc Filr Page |